Adcock Ingram is a finished-dose manufacturer based in South Africa. It appears in 1,688 regulatory filings across 9 regulators, without an active US DMF or CEP on file. Its filings concentrate with SAHPRA (ZA), NMRC (NA) and MCAZ (ZW). Its GMP standing is certified by CDSCO (India), FDA (GH) and MCAZ (ZW), among 4 authorities. Customs aggregates show $45.8M of exports covering 1,889 molecules to 14 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Bommasandra, India | Not on file |
| Bengaluru, India | Not on file |
| bengaluru 562 106, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| SAHPRA (ZA) | 1,317 | None |
| NMRC (NA) | 302 | None |
| MCAZ (ZW) | 46 | 1 |
| ZAMRA (ZM) | 10 | None |
| PPB (KE) | 7 | None |
| INVIMA (CO) | 3 | None |
| CDSCO (India) | None | 2 |
| FDA (GH) | None | 2 |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $8.5M | 9 |
| 2025 | Not reported | $45.8M | 14 |
| 2024 | $499.6M | $58.4M | 7 |
| 2023 | $466.8M | $50.2M | 6 |
| 2022 | $494.8M | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Choose your molecules and target markets. Adcock Ingram comes back tiered against every other supplier able to file there.
Start for free